A 13-year survey of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 and PCV13 implementation

Vaccine

Volumn 33, Issue 39, 2015, Pages 5118-5126

  Cohen, Robert ^a,b,c,d   Varon, Emmanuelle ^e   Doit, Catherine ^f,g   Schlemmer, Catherine ^b   Romain, Olivier ^b   Thollot, Franck ^b,d   Béchet, Stéphane ^b   Bonacorsi, Stéphane ^f,g   Levy, Corinne ^a,b,c,d  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b ACTIV   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^d Association Française de Pédiatrie Ambulatoire   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Acute otitis media; Children; PCV7 and PCV13 impact; Pneumococcal nasopharyngeal carriage

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; 13-VALENT PNEUMOCOCCAL VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; CHILD; FEMALE; FEVER; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RISK ASSESSMENT; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; VACCINATION; CLASSIFICATION; FRANCE; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIOLOGY; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; PREVALENCE; PREVENTION AND CONTROL; PROSPECTIVE STUDY;

CARRIER STATE; CHILD, PRESCHOOL; FEMALE; FRANCE; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; HUMANS; INFANT; MALE; NASOPHARYNX; OTITIS MEDIA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE;

EID: 84941642622     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.08.010     Document Type: Article

References (44)

1. Simell B., Auranen K., Kayhty H., Goldblatt D., Dagan R., O'Brien K.L. The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines 2012, 11(7):841-855.
2. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4(3):144-154.
3. Satzke C., Turner P., Virolainen-Julkunen A., Adrian P.V., Antonio M., Hare K.M., Leach A.J., Porter B.D., Scott J.A., O'Brien K.L., et al. Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group. Vaccine 2013, 32(1):165-179.
4. Dagan R. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Clin Microbiol Infect 2009, 15(Suppl 3):16-20.
5. Revai K., McCormick D.P., Patel J., Grady J.J., Saeed K., Chonmaitree T. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media. Pediatrics 2006, 117(5):1823-1829.
6. Hau I., Levy C., Caeymaex L., Cohen R. Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis media. Paediatr Drugs 2014, 16(1):1-12.
7. Feikin D.R., Kagucia E.W., Loo J.D., Link-Gelles R., Puhan M.A., Cherian T., Whitney C.G., Moore M.R., et al. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med 2013, 10(9):e1001517.
8. Spijkerman J., Prevaes S.M., van Gils E.J., Veenhoven R.H., Bruin J.P., Bogaert D., van den Dobbelsteen G.P., et al. Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One 2012, 7(6):e39730.
9. Lepoutre A., Varon E., Georges S., Gutmann L., Levy-Bruhl D. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill 2008, 13.(35).
10. Martinot A., Cohen R., Denis F., Gaudelus J., Lery T., Le Danvic M., et al. Annual trends (2008-2011) in early childhood vaccination coverage for the French population: the vaccinoscopie((R)) study. Arch Pediatrie 2013, 20(8):837-844.
11. Anonymous French vaccinal calendar recommendations 2010, http://www.invssantefr/beh/2010/14_15/beh_14_15pdf.
12. Cohen R., Bingen E., Varon E., de La Rocque F., Brahimi N., Levy C., Langue J., et al. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr Infect Dis J 1997, 16(6):555-560.
13. Cohen R., Levy C., de La Rocque F., Gelbert N., Wollner A., Fritzell B., Tetelboum R., et al. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J 2006, 25(11):1001-1007.
14. Shouval D.S., Greenberg D., Givon-Lavi N., Porat N., Dagan R. Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis. Pediatr Infect Dis J 2006, 25(7):602-607.
15. Cohen R., Levy C., Bonnet E., Grondin S., Desvignes V., Lecuyer A., Varon E., et al. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 2010, 28(37):6114-6121.
16. Paradise J.L. On classifying otitis media as suppurative or nonsuppurative, with a suggested clinical schema. J Pediatr 1987, 111(6 Pt 1):948-951.
17. Palmu A.A., Herva E., Savolainen H., Karma P., Makela P.H., Kilpi T.M. Association of clinical signs and symptoms with bacterial findings in acute otitis media. Clin Infect Dis 2004, 38(2):234-242.
18. Howie V.M., Ploussard J.H., Lester R.L. Otitis media: a clinical and bacteriological correlation. Pediatrics 1970, 45(1):29-35.
19. Lee H., Cha J.H., Nahm M.H., Burton R.L., Kim K.H. The 7-valent pneumococcal conjugate vaccine elicits cross-functional opsonophagocytic killing responses to Streptococcus pneumoniae serotype 6D in children. BMC Infect Dis 2013, 13:474.
20. Cohen R., Levy C., Bingen E., Koskas M., Nave I., Varon E. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr Infect Dis J 2012, 31(3):297-301.
21. Dagan R., Patterson S., Juergens C., Greenberg D., Givon-Lavi N., Porat N., Gruber W.C., et al. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial. Clin Infect Dis 2013, 57(7):952-962.
22. Loughlin A.M., Hsu K., Silverio A.L., Marchant C.D., Pelton S.I. Direct and indirect effects of PCV13 on nasopharyngeal carriage of PCV13 unique pneumococcal serotypes in Massachusetts' children. Pediatr Infect Dis J 2014, 33(5):504-510.
23. Snape M.D., Klinger C.L., Daniels E.D., John T.M., Layton H., Rollinson L., Dymond S., Tansey S., Baker S.A., Yu L.M., Emini E.A., Finn A., Pollard A.J., et al. Immunogenicity and reactogenicity of a 13-valent-pneumococcal conjugate vaccine administered at 2, 4, and 12 months of age: a double-blind randomized active-controlled trial. Pediatr Infect Dis J 2010, 29(12):e80-e90.
24. Dagan R., Juergens C., Trammel J., Patterson S., Greenberg D., Givon-Lavi N., Gurtman A., Scott D.A., et al. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible streptococcus pneumoniae. J Infect Dis 2014.
25. Dagan R., Klugman K.P. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 2008, 8(12):785-795.
26. van Hoek A.J., Sheppard C.L., Andrews N.J., Waight P.A., Slack M.P., Harrison T.G., Miller E., et al. Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England. Vaccine 2014, 32(34):4349-4355.
27. Ricketson L.J., Wood M.L., Vanderkooi O.G., MacDonald J.C., Martin I.E., Demczuk W.H., et al. Trends in asymptomatic nasopharyngeal colonization with streptococcus pneumoniae after introduction of the 13-valent pneumococcal conjugate vaccine in Calgary, Canada. Pediatr Infect Dis J 2014, 33(7):724-730.
28. McElligott M., Vickers I., Cafferkey M., Cunney R., Humphreys H. Non-invasive pneumococcal serotypes and antimicrobial susceptibilities in a paediatric hospital in the era of conjugate vaccines. Vaccine 2014, 32(28):3495-3500.
29. Martin J.M., Hoberman A., Paradise J.L., Barbadora K.A., Shaikh N., Bhatnagar S., Block S.L., Kurs-Lasky M., Green M., et al. Emergence of Streptococcus pneumoniae serogroups 15 and 35 in nasopharyngeal cultures from young children with acute otitis media. Pediatr Infect Dis J 2014, 33(11):e286-e290.
30. Liyanapathirana V., Nelson E.A., Ang I., Subramanian R., Ma H., Ip M. Emergence of serogroup 15 Streptococcus pneumoniae of diverse genetic backgrounds following the introduction of pneumococcal conjugate vaccines in Hong Kong. Diagn Microbiol Infect Dis 2015, 81(1):66-70.
31. Lee G.M., Kleinman K., Pelton S.I., Hanage W., Huang S.S., Lakoma M., Croucher N.J., Finkelstein J.A., et al. Impact of 13-valent pneumococcal conjugate vaccination on carriage in young children in Massachusetts. J Pediatr Infect Dis Soc 2014, 3(1):23-32.
32. Ho P.L., Chiu S.S., Law P.Y., Chan E.L., Lai E.L., Chow K.H. Increase in the nasopharyngeal carriage of non-vaccine serogroup 15 Streptococcus pneumoniae after introduction of children pneumococcal conjugate vaccination in Hong Kong. Diagn Microbiol Infect Dis 2014.
33. Camilli R., Daprai L., Cavrini F., Lombardo D., D'Ambrosio F., Del Grosso M., Landini M.P., Torresani E., Sambri V., et al. Pneumococcal carriage in young children one year after introduction of the 13-valent conjugate vaccine in Italy. PLOS ONE 2013, 8(10):e76309.
34. Weinberger D.M., Trzcinski K., Lu Y.J., Bogaert D., Brandes A., Galagan J., Malley R., et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog 2009, 5(6):e1000476.
35. Sharma D., Baughman W., Holst A., Thomas S., Jackson D., da Gloria Carvalho M., Satola S., Jain S., Nuorti J.P., et al. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine. Pediatr Infect Dis J 2013, 32(2):e45-e53.
36. Azzari C., Martinon-Torres F., Schmitt H.J., Dagan R. Evolving role of 13-valent pneumococcal conjugate vaccine in clinical practice. Pediatr Infec Dis J 2014, 33(8):858-864.
37. Kouchner B. National plan to promote prudent antibiotic use 2001, Available at: http://www.santegouvfr/htm/actu/antibio/indexhtm.
38. Miller E., Andrews N.J., Waight P.A., Slack M.P., George R.C. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine 2011, 29(49):9127-9131.
39. Ben-Shimol S., Givon-Lavi N., Leibovitz E., Raiz S., Greenberg D., Dagan R. Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV. Clin Infect Dis 2014, 59(12):1724-1732.
40. Angoulvant F., Levy C., Grimprel E., Varon E., Lorrot M., Biscardi S., Dommergues M.A., Gillet Y., Zenkhri F., Guen C.G., Martinot A., et al. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children. Clin Infect Dis 2014, 58(7):918-924.
41. Turner P., Hinds J., Turner C., Jankhot A., Gould K., Bentley S.D., Goldblatt D., et al. Improved detection of nasopharyngeal cocolonization by multiple pneumococcal serotypes by use of latex agglutination or molecular serotyping by microarray. J Clin Microbiol 2011, 49(5):1784-1789.
42. Dagan R., Leibovitz E., Greenberg D., Bakaletz L., Givon-Lavi N. Mixed pneumococcal-nontypeable Haemophilus influenzae otitis media is a distinct clinical entity with unique epidemiologic characteristics and pneumococcal serotype distribution. J Infect Dis 2013, 208(7):1152-1160.
43. Hsu K.K., Rifas-Shiman S.L., Shea K.M., Kleinman K.P., Lee G.M., Lakoma M., Finkelstein J.A., et al. Do community-level predictors of pneumococcal carriage continue to play a role in the conjugate vaccine era?. Epidemiol Infect 2014, 142(2):379-387.
44. Cohen R., Levy C., Hentgen V., Boucherat M., de La Rocque F., d'Athis P., et al. Relationship between clinical signs and symptoms and nasopharyngeal flora in acute otitis media. Clin Microbiol Infect 2006, 12(7):679-682.